Semma Therapeutics

Semma Therapeutics

New class of regenerative medicine therapies couples its breakthrough stem cell technologies with proprietary delivery systems designed to protect cells from the immune system
Cambridge United States (HQ)

Semma Therapeutics Company information

Edit
Launch date
Employees
3,240 people
Firm valuation
€864m (Dealroom.co estimates Sep 2019.)
  • Edit
DateInvestorsAmountRound
$44mSERIES A
$5mGRANT
N/ALATE VC
N/A$114mSERIES B
$950m
ACQUISITION*
Total Funding€148m

Recent News about Semma Therapeutics

Edit
LocationEdit
United States, Cambridge
Are you an employee or an investor of this company?
Add your profile